Bridgewater Associates’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-97,308
Closed -$2.31M 824
2023
Q3
$2.31M Sell
97,308
-6,626
-6% -$125K 0.01% 479
2023
Q2
$1.69M Sell
103,934
-6,024
-5% -$99.8K 0.01% 493
2023
Q1
$1.91M Sell
109,958
-5,648
-5% -$102K 0.01% 465
2022
Q4
$2.17M Sell
115,606
-39,024
-25% -$752K 0.01% 523
2022
Q3
$2.74M Sell
154,630
-1,712
-1% -$29.7K 0.01% 494
2022
Q2
$2.73M Buy
156,342
+8,245
+6% +$157K 0.01% 616
2022
Q1
$3.1M Buy
148,097
+31,587
+27% +$605K 0.01% 585
2021
Q4
$2.07M Sell
116,510
-2,548
-2% -$40.9K 0.01% 458
2021
Q3
$1.68M Sell
119,058
-1,184
-1% -$18.4K 0.01% 455
2021
Q2
$2M Buy
+120,242
New +$2.15M 0.01% 486

Other funds holding NXGN

Bridgewater Associates's NXGN Position: Q4 2023 in Review

Bridgewater Associates sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 97,308 shares — an estimated $2.31M sold.

Bridgewater Associates first reported a position in NXGN in Q2 2021 and held it in 10 quarters. The position peaked at $3.1M in Q1 2022. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Bridgewater Associates reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bridgewater Associates sold 97,308 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $2.31M.
  • Bridgewater Associates first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Bridgewater Associates's NextGen Healthcare, Inc. Common Stock position peaked at $3.1M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Bridgewater Associates's 13F filing for Q4 2023, filed 14 Feb 2024.